My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 103

1.

Recent advances in systemic therapy: advances in neoadjuvant (primary) systemic therapy with cytotoxic agents.

Untch M, von Minckwitz G.

Breast Cancer Res. 2009;11(2):203. Epub 2009 Mar 17. Review.PMID: 19344488 [PubMed - indexed for MEDLINE]Related articlesFree article

2.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.PMID: 17993229 [PubMed - indexed for MEDLINE]Related articles

3.

Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.

Goble S, Bear HD.

Surg Clin North Am. 2003 Aug;83(4):943-71. Review.PMID: 12875604 [PubMed - indexed for MEDLINE]Related articles

4.

Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.

Gralow JR, Burstein HJ, Wood W, Hortobagyi GN, Gianni L, von Minckwitz G, Buzdar AU, Smith IE, Symmans WF, Singh B, Winer EP.

J Clin Oncol. 2008 Feb 10;26(5):814-9. Review.PMID: 18258991 [PubMed - indexed for MEDLINE]Related articles

5.

Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?

Freedman OC, Verma S, Clemons MJ.

Cancer Treat Rev. 2005 Feb;31(1):1-17. Epub 2004 Nov 18. Review.PMID: 15707700 [PubMed - indexed for MEDLINE]Related articles

6.

Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer.

Shenkier T, Weir L, Levine M, Olivotto I, Whelan T, Reyno L; Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.

CMAJ. 2004 Mar 16;170(6):983-94. Review.PMID: 15023926 [PubMed - indexed for MEDLINE]Related articlesFree article

7.

Current and future roles of neoadjuvant chemotherapy in operable breast cancer.

Kim R, Osaki A, Toge T.

Clin Breast Cancer. 2005 Aug;6(3):223-32; discussion 233-4. Review.PMID: 16137432 [PubMed - indexed for MEDLINE]Related articles

8.

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.

Powles TJ, Hickish TF, Makris A, Ashley SE, O'Brien ME, Tidy VA, Casey S, Nash AG, Sacks N, Cosgrove D, et al.

J Clin Oncol. 1995 Mar;13(3):547-52.PMID: 7884414 [PubMed - indexed for MEDLINE]Related articles

9.

Neoadjuvant chemotherapy for locally advanced breast cancer.

Specht J, Gralow JR.

Semin Radiat Oncol. 2009 Oct;19(4):222-8. Review.PMID: 19732686 [PubMed - indexed for MEDLINE]Related articles

10.

[Neoadjuvant therapy for operable breast-cancer]

Insa A, Chirivella I, Lluch A.

Med Clin (Barc). 2006 Mar 4;126(8):295-303. Review. Spanish. PMID: 16527157 [PubMed - indexed for MEDLINE]Related articles

11.

Evidence-based use of neoadjuvant taxane in operable and inoperable breast cancer.

Estévez LG, Gradishar WJ.

Clin Cancer Res. 2004 May 15;10(10):3249-61. Review.PMID: 15161677 [PubMed - indexed for MEDLINE]Related articlesFree article

12.

Future prospects of neoadjuvant chemotherapy in treatment of primary breast cancer.

Wang HC, Lo SS.

Semin Surg Oncol. 1996 Jan-Feb;12(1):59-66. Review.PMID: 8821411 [PubMed - indexed for MEDLINE]Related articles

13.

[Role of radiation therapy on the use of primary ("neoadjuvant") systemic treatment of breast cancer]

Souchon R, Dunst J, Hartmann KA.

Strahlenther Onkol. 2006 Apr;182(4):202-9. Review. German. PMID: 16622621 [PubMed - indexed for MEDLINE]Related articles

14.

Breakthrough for neoadjuvant chemotherapy.

von Minckwitz G.

Breast Cancer. 2008;15(1):27-30.PMID: 18224390 [PubMed - indexed for MEDLINE]Related articles

15.

Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.

Mauri D, Pavlidis N, Ioannidis JP.

J Natl Cancer Inst. 2005 Feb 2;97(3):188-94.PMID: 15687361 [PubMed - indexed for MEDLINE]Related articlesFree article

16.

Primary (neoadjuvant) chemotherapy with docetaxel in breast cancer.

Gradishar WJ.

Clin Breast Cancer. 2001 Oct;2 Suppl 1:S31-5. Review.PMID: 11970742 [PubMed - indexed for MEDLINE]Related articlesFree article

17.

Is there still a role for neoadjuvant therapy in breast cancer?

Shannon C, Smith I.

Crit Rev Oncol Hematol. 2003 Jan;45(1):77-90. Review.PMID: 12482573 [PubMed - indexed for MEDLINE]Related articles

18.

Locally advanced breast cancer.

Sikov WM.

Curr Treat Options Oncol. 2000 Aug;1(3):228-38. Review.PMID: 12057165 [PubMed - indexed for MEDLINE]Related articles

19.

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort.

Gianni L, Eiermann W, Semiglazov V, Manikhas A, Lluch A, Tjulandin S, Zambetti M, Vazquez F, Byakhow M, Lichinitser M, Climent MA, Ciruelos E, Ojeda B, Mansutti M, Bozhok A, Baronio R, Feyereislova A, Barton C, Valagussa P, Baselga J.

Lancet. 2010 Jan 30;375(9712):377-84.PMID: 20113825 [PubMed - indexed for MEDLINE]Related articles

20.

Neoadjuvant chemotherapy for operable breast cancer.

Green M, Hortobagyi GN.

Oncology (Williston Park). 2002 Jul;16(7):871-84, 889; discussion 889-90, 892-4, 897-8. Review.PMID: 12164555 [PubMed - indexed for MEDLINE]Related articles

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Write to the Help Desk